
Buprocare 0.2mg Tablet
Marketer
Gentech Healthcare Pvt Ltd
Salt Composition
Buprenorphine (0.2mg)
Overview Buprocare 0.2mg Tablet
Opioid withdrawal symptoms are managed with Buprocare 0.2mg tablets, effective in treating morphine dependence. This medication aids in mitigating withdrawal effects from other opioids, forming a component of a comprehensive treatment strategy incorporating counseling and lifestyle adjustments. Prescribed only to patients aged 16 and older, Buprocare 0.2mg tablets possess addictive potential and must be administered precisely as directed by a physician. Treatment may include psychosocial support. Consumption is independent of food intake; consistent daily use, as advised by your doctor, is crucial to maintain efficacy. Missed doses diminish effectiveness. Potential side effects include weakness, withdrawal symptoms, anxiety, restlessness, vertigo, headache, somnolence, diarrhea, nausea, emesis, and abdominal discomfort. Persistent or worsening side effects necessitate medical consultation. Your physician can offer strategies for symptom management or reduction. Prior to commencing Buprocare 0.2mg tablets, disclose any existing medical conditions or medications to your doctor to ensure safety. This includes informing your doctor if you are pregnant or breastfeeding.
Uses of Buprocare 0.2mg Tablet
Moderate to severe pain managed with morphine, a potent opioid.
Major Benefits of Buprocare 0.2mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Buprocare 0.2mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Buprocare 0.2mg Tablet:
- Headache
- Drug withdrawal syndrome
- Back pain
- Drowsiness
- Vomiting
- Insomnia (difficulty in sleeping)
- Dizziness
- Abdominal pain
- Weakness
- Sleepiness
- Sweating
- Constipation
- Withdrawal syndrome
- Infection
- Vertigo
- Inflammation of the nose
- Chills
- Flu-like symptoms
- Nausea
How to use Buprocare 0.2mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Buprocare 0.2mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Buprocare 0.2mg Tablet works:
Suboxone 0.2mg tablets function as a partial opioid agonist, mitigating withdrawal symptoms in individuals discontinuing opioid use by mimicking the effects of these medications.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Buprocare 0.2mg tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Buprocare 0.2mg Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against the risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Buprocare 0.2mg tablets while breastfeeding is likely unsafe. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Buprocare 0.2mg tablets may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Buprocare 0.2mg tablets. Dosage modification may be necessary; physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use 0.2mg Buprocare tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Buprocare 0.2mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Buprocare 0.2mg Tablet :
NA
Facts to Know About Buprocare 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenanthrene Derivatives |
| Developing Habits | Affirmative. |
| Type of Treatment | Neuroscience of the Central Nervous System |
| Action Class | Partial Opioid Agonists |
